Specify a stock or a cryptocurrency in the search bar to get a summary
Immunovia publ AB
IMMNOVImmunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 63
Analytics
WallStreet Target Price
1 082.22 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures IMMNOV
Dividend Analytics IMMNOV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IMMNOV
Stock Valuation IMMNOV
Financials IMMNOV
Results | 2019 | Dynamics |